ImmunityBio (IBRX) P/B ratio

P/B ratio · fiscal 2019
11.5×

Only 1 fiscal year of P/B ratio is on record here for ImmunityBio (IBRX); a history needs at least 3. Figures as of 18 Nov 2026, 07:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio, fiscal 2019
11.5×
Fiscal years on record
12019–2019

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/B ratio needs at least 3 fiscal years; one is on record here for ImmunityBio. Nothing is estimated to fill the gap. What is on record is in the table below.

ImmunityBio P/B ratio, year by year

ImmunityBio (IBRX) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
2025——$1.98-$0.54
2024——$2.56-$0.70
2023——$5.02-$1.15
2022——$5.07-$1.12
2021——$6.08-$0.62
2020——$13.33-$0.32
201911.5×—$3.79$0.33
2018——$1.16—
2017——$4.49—
2016——$5.72—
2015——$17.33—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of ImmunityBio and comparable companies
CompanyP/B ratio
Alkermes ALKS4.2×
PACS Group PACS8.1×
Kiniksa Pharmaceuticals International KNSA13.2×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on IBRX

ImmunityBio, figure by figure

ImmunityBio (IBRX) overview: price, valuation and scorecardAll health care companies by market value

ImmunityBio P/B ratio: questions and answers

How is ImmunityBio's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ImmunityBio (IBRX) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IBRX/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.